A new trading day began on Friday, with Cns Pharmaceuticals Inc (NASDAQ: CNSP) stock price down -22.93% from the previous day of trading, before settling in for the closing price of $3.62. CNSP’s price has ranged from $3.06 to $137.50 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
With a float of $0.23 million, this company’s outstanding shares have now reached $0.24 million.
Let’s determine the extent of company efficiency that accounts for 5 employees.
Cns Pharmaceuticals Inc (CNSP) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Cns Pharmaceuticals Inc is 3.41%, while institutional ownership is 8.21%. The most recent insider transaction that took place on Feb 01 ’24, was worth 50,000. In this transaction Chief Executive Officer of this company bought 166,666 shares at a rate of $0.30, taking the stock ownership to the 215,676 shares. Before that another transaction happened on Feb 01 ’24, when Company’s Chief Financial Officer bought 66,666 for $0.30, making the entire transaction worth $20,000. This insider now owns 103,438 shares in total.
Cns Pharmaceuticals Inc (CNSP) Recent Fiscal highlights
In its latest quarterly report, released on 9/30/2022, the company reported earnings of -2.1 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
Cns Pharmaceuticals Inc (NASDAQ: CNSP) Trading Performance Indicators
Here are Cns Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.26.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -174.04
Technical Analysis of Cns Pharmaceuticals Inc (CNSP)
Looking closely at Cns Pharmaceuticals Inc (NASDAQ: CNSP), its last 5-days average volume was 2.09 million, which is a jump from its year-to-date volume of 0.11 million. As of the previous 9 days, the stock’s Stochastic %D was 4.86%. Additionally, its Average True Range was 1.73.
During the past 100 days, Cns Pharmaceuticals Inc’s (CNSP) raw stochastic average was set at 0.00%, which indicates a significant increase from 0.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 254.04% in the past 14 days, which was higher than the 156.72% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.55, while its 200-day Moving Average is $45.15. However, in the short run, Cns Pharmaceuticals Inc’s stock first resistance to watch stands at $6.45. Second resistance stands at $10.11. The third major resistance level sits at $11.94.
Cns Pharmaceuticals Inc (NASDAQ: CNSP) Key Stats
With a market capitalization of 0.67 million, the company has a total of 237K Shares Outstanding. Currently, annual sales are 0 K while annual income is -18,850 K. The company’s previous quarter sales were 0 K while its latest quarter income was -3,540 K.
